Publication:

Stevens-Johnson syndrome induced by gabapentin and cilostazol in diabetic patient co-infected with COVID-19

Coronavirus disease 2019 (COVID-19) has been declared as an emergent pandemic. COVID-19 mainly present with fever and respiratory symptoms. Its severity ranges from asymptomatic infection, mild, moderate, severe to critical degrees which is related to the degree of dysregulated inflammatory response and systemic inflammation. Stevens-Johnson syndrome (SJS), on the other hand is a rare, severe, type IV hypersensitivity presenting with epithelial destruction of skin and mucous membranes. This condition also associated with systemic proinflammatory state. We report a case of a 73-years-old woman with dry cough and fever, who recently started treatment with cilostazol and gabapentin, then followed by redness and blistering on her lips, trunk, and genital which subsequently diagnosed with COVID-19 and SJS.